Dennis Gillings, CBE, chairman and chief executive officer of Quintiles Transnational Corp., dedicated a new facility in Overland Park, KS, with Secretary David Kerr of the Kansas Department of Commerce. The 236,000-sq.-ft. building will house Quintiles’ regional Clinical Development Services (CDS) and clinical pharmacology units previously located in Kansas City, MO, as well as the Phase I clinical research unit that had been in Lenexa, KS. The new Phase I unit has a 150-bed capacity—...